Key metrics and charts across all fundamental categories.
Stock price and market valuation
DDS trades at $581.53, a 60.0% increase year-over-year. Market capitalization stands at $9.08B, up 58.4% from the prior year. Track DDS price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$6.51B in TTM revenue grew 0.8% YoY, reaching $1.57B last quarter. TTM EBITDA of $980.26M on operating income of $254.08M shows growth is flowing through. Net income of $656.92M TTM confirms the company is converting revenue into profit. Revenue is growing modestly — monitor for acceleration or deceleration.
Assets, cash, debt, and leverage
With $4.14B in assets and $200.00M in long-term debt, the D/E of 0.1 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 13.8x P/E, the stock trades below market averages — potentially undervalued. P/S of 1.4x and P/B of 4.5x provide additional context. Assess whether the current multiple is justified by the company's growth and profitability trajectory.
Operating efficiency and return metrics
Op. margin of 16.2% is down 0.1% YoY — costs are rising relative to revenue. Net margin at 16.0% and gross margin of 44.5%. ROE of 32.4% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $346.77M on $363.98M in operating cash flow. The FCF / Net Income ratio of 0.5x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $1.16B provide financial flexibility. Share count is stable — no dilution or buyback activity.
